滚动资讯
Roche MediaRoche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics - Pharmaceutical TechnologyEndpoints NewsIncyte to buy bleeding disorder biotech Vega Therapeutics in $1.25B upfront dealEndpoints NewsTakeda says it expects to take $2.5B hit after Amitiza antitrust verdict, with plans to appealEndpoints NewsNurix与罗氏达成合作，共同开发BTK降解剂，交易价值高达23亿美元FierceBiotechADA：勃林格高管声称survodutide耐受性与同类药物"一致"，尽管三期数据更新FierceBiotech罗氏豪掷7亿美元首付款，押注Nurix后期阶段BTK降解剂，剑指礼来对决BioPharma Dive生物制药领域，仅靠创新已不足以制胜BioPharma Dive精准压力下：核医学规模化发展的物流解决方案Lonza NewsLonza and Stipple Bio strike licensing deal for precision oncology ADCs - BioXconomyRoche Media罗氏韩国为K-Swiss BioPass项目选定4家韩国生物科技公司 - koreabiomed.comFierceBiotech激活免疫系统能否改善急性髓系白血病预后？FierceBiotech为何人工智能正在改变临床开发

资讯库

最新 最旧 清除
@Endpoints News
总数 1336
来源 Endpoints News
搜索 --